Overview

Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery

Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of OMS302 on the signs of Intraoperative Floppy Iris Syndrome in patients at risk.
Phase:
Phase 3
Details
Lead Sponsor:
Omeros Corporation
Treatments:
Citric Acid
Pharmaceutical Solutions